Resistance mutation info of target

Target General Information
Target ID T67619
Target Name RAC-alpha serine/threonine-protein kinase (AKT1) Target Info
Gene Name AKT1
Species Homo sapiens
Uniprot ID AKT1_HUMAN
Sequence MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQC
QLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDF
RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI
LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS
RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI
KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL
ILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKK
LSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA
[Homo sapiens]
Drug Resistance Mutation and Corresponding Drugs
Ref 556264Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
Mutation Info Missense: E17K
Drugs
Drug Name Dabrafenib Drug Info [555980]
Targeted Disease Melanoma
Mutation Info Missense: Q79K
Drugs
Drug Name Dabrafenib Drug Info [555980]
Targeted Disease Melanoma
Reference
Ref 555980A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition. Cancer Discov. 2014 Jan;4(1):69-79. doi: 10.1158/2159-8290.CD-13-0279. Epub 2013 Nov 21.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.